Pure Global

MAGLUMI Aldosterone - India CDSCO Medical Device Registration

MAGLUMI Aldosterone is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000060_f09a6fcdeba287bc712bfcbd60d485c1_5a023ca220460a1bbaea23255c01b7db. This device is marketed under the brand name CLIA. The license holder is M/s. Golden Harvest Industries, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
MAGLUMI Aldosterone
UID: IMP/IVD/2020/000060_f09a6fcdeba287bc712bfcbd60d485c1_5a023ca220460a1bbaea23255c01b7db

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of Aldosterone (CLIA) in human serum, plasma and treated urine with the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer (CLIA)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing